Series on pharmacology in practice. 2. Antiarrhythmic drug therapy.

Federman, J; Vlietstra, R E

Federman, J; Vlietstra, R E.

Mayo Clin Proc ; 54(8): 531-42, 1979 Aug.

Article in En | MEDLINE | ID: mdl-459565

Subject(s)

Anti-Arrhythmia Agents/therapeutic use; Anti-Arrhythmia Agents/classification; Anti-Arrhythmia Agents/metabolism; Bretylium Compounds/metabolism; Bretylium Compounds/therapeutic use; Disopyramide/metabolism; Disopyramide/therapeutic use; Humans; Lidocaine/metabolism; Lidocaine/therapeutic use; Metoprolol/metabolism; Metoprolol/therapeutic use; Procainamide/metabolism; Procainamide/therapeutic use; Propranolol/metabolism; Propranolol/therapeutic use; Quinidine/metabolism; Quinidine/therapeutic use; Verapamil/metabolism; Verapamil/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Arrhythmia Agents Limits: Humans Language: En Journal: Mayo Clin Proc Year: 1979 Type: Article

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Arrhythmia Agents Limits: Humans Language: En Journal: Mayo Clin Proc Year: 1979 Type: Article